Wells Fargo Maintains Equal-Weight on National Health Investors, Raises Price Target to $55
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Todd Stender has maintained an Equal-Weight rating on National Health Investors (NYSE:NHI) and increased the price target from $54 to $55.
November 27, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo analyst Todd Stender maintains an Equal-Weight rating on National Health Investors and raises the price target from $54 to $55.
The increase in price target by Wells Fargo suggests a slightly more optimistic outlook on NHI's stock, which could lead to positive investor sentiment in the short term. However, since the rating remains at Equal-Weight, the impact may be moderate rather than strong.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100